- Reducing the risk of nonsteroidal anti-inflammatory agent-induced gastric ulcer.
- Short-term treatment of active duodenal ulcer and active benign gastric ulcer.
- Maintenance therapy following healing of gastric ulcer to reduce ulcer recurrence.
- Adjunct to mifepristone for the medical termination of intrauterine pregnancy according to the “National Guideline on reproductive health care services” issued together with the Minister of Health’s Decision No. 4128 / QD-BYT dated July 29, 2016.
- Preventing ulcers caused by NSAIDs:
200 mcg 4 times daily, dosage may be reduced to 100 mcg 4 times daily in patients who do not tolerate the usual dosage.
- Stomach ulcer: Short-term treatment.
100 or 200 mcg 4 times daily for 8 weeks.
- Duodenal ulcer: Short-term treatment.
100 or 200 mcg 4 times daily or 400 mcg twice daily for 4 to 8 weeks.
- Support mifepristone in abortion:
In accordance with “National Guideline on reproductive health care services” issued together with Decision No. 4128 / QD-BYT dated July 29, 2016 of the Minister of Health.
Misoclear is administered orally. The incidence of misoprostol induced diarrhea may be minimized by using in divided doses after meals and at bedtime and by avoiding concomitantly use with a magnesium-containing or other laxative antacid..